Vanguard Global Advisers »

Anika Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Anika Therapeutics (ANIK) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Anika Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Anika Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anika Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 4.3k 14.50

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Anika Therapeutics

BlackRock
Caligan Partners
Morgan Stanley
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Boothbay Fund Management
Renaissance Technologies
Dimensional Fund Advisors
Capital Management Corporation
Deutsche Bank Aktiengesellschaft
State Street Corporation
Geode Capital Management
AQR Capital Management
Jacobs Levy Equity Management

View all funds holding Anika Therapeutics